These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 9091574)

  • 1. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation.
    Udagawa N; Horwood NJ; Elliott J; Mackay A; Owens J; Okamura H; Kurimoto M; Chambers TJ; Martin TJ; Gillespie MT
    J Exp Med; 1997 Mar; 185(6):1005-12. PubMed ID: 9091574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.
    Horwood NJ; Udagawa N; Elliott J; Grail D; Okamura H; Kurimoto M; Dunn AR; Martin T; Gillespie MT
    J Clin Invest; 1998 Feb; 101(3):595-603. PubMed ID: 9449693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.
    Morgan H; Tumber A; Hill PA
    Int J Cancer; 2004 May; 109(5):653-60. PubMed ID: 14999770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
    Romas E; Udagawa N; Zhou H; Tamura T; Saito M; Taga T; Hilton DJ; Suda T; Ng KW; Martin TJ
    J Exp Med; 1996 Jun; 183(6):2581-91. PubMed ID: 8676079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro.
    Horwood NJ; Elliott J; Martin TJ; Gillespie MT
    J Immunol; 2001 Apr; 166(8):4915-21. PubMed ID: 11290769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro.
    Balani D; Aeberli D; Hofstetter W; Seitz M
    Arthritis Rheum; 2013 Feb; 65(2):436-46. PubMed ID: 23124514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene.
    Matsuzaki K; Katayama K; Takahashi Y; Nakamura I; Udagawa N; Tsurukai T; Nishinakamura R; Toyama Y; Yabe Y; Hori M; Takahashi N; Suda T
    Endocrinology; 1999 Feb; 140(2):925-32. PubMed ID: 9927325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CytokineRegulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formation.
    Koide M; Maeda H; Roccisana JL; Kawanabe N; Reddy SV
    J Bone Miner Res; 2003 Mar; 18(3):458-65. PubMed ID: 12619930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts.
    Lee SK; Kalinowski J; Jastrzebski S; Lorenzo JA
    J Immunol; 2002 Sep; 169(5):2374-80. PubMed ID: 12193704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor-dependent CD11c-positive cells differentiate into active osteoclasts.
    Ruef N; Dolder S; Aeberli D; Seitz M; Balani D; Hofstetter W
    Bone; 2017 Apr; 97():267-277. PubMed ID: 28161590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen via the estrogen receptor blocks cAMP-mediated parathyroid hormone (PTH)-stimulated osteoclast formation.
    Kanatani M; Sugimoto T; Takahashi Y; Kaji H; Kitazawa R; Chihara K
    J Bone Miner Res; 1998 May; 13(5):854-62. PubMed ID: 9610750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
    Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
    Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis.
    Grcević D; Lee SK; Marusić A; Lorenzo JA
    J Immunol; 2000 Oct; 165(8):4231-8. PubMed ID: 11035056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A third-generation bisphosphonate, YM175, inhibits osteoclast formation in murine cocultures by inhibiting proliferation of precursor cells via supporting cell-dependent mechanisms.
    Nishikawa M; Yamamoto M; Murakami T; Akatsu T; Kugai N; Nagata N
    J Bone Miner Res; 1998 Jun; 13(6):986-95. PubMed ID: 9626630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation.
    Haynes DR; Atkins GJ; Loric M; Crotti TN; Geary SM; Findlay DM
    Bone; 1999 Sep; 25(3):269-78. PubMed ID: 10495130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
    Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
    Nagai M; Sato N
    Biochem Biophys Res Commun; 1999 Apr; 257(3):719-23. PubMed ID: 10208850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures.
    Menaa C; Devlin RD; Reddy SV; Gazitt Y; Choi SJ; Roodman GD
    J Clin Invest; 1999 Jun; 103(11):1605-13. PubMed ID: 10359570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.